Bad news first because I felt the good news over-shadowed the bad
Product sales revenues sucked.
Zero patients enrolled in ATHENA trials during Q3
Japan was really mixed news imho...a lot of dancing on the topic with I felt no clear timelines of final sign off other than they still seem to feel 2015 implementation happening.
The good news
BARDA really seems on track for phase 2, although they backed away from Q1 for money to 1st half 2014...no biggie since we have cash again.
The biggest positive was the Lorem partnership talk. Calhoun actually did a excellent job on the answers and disclosures !!! Who knew..LOL ! Anyway, liking what seems to be in place with this partner and now it will be about execution which they seem to already be moving on.
CC also at the end hinted to beating 14 million in total revenues...jury will be out til March 2014 on that.